Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL)
Yıl: 2015 Cilt: 52 Sayı: 2 Sayfa Aralığı: 128 - 132 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022
Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL)
Öz: Amaç: Bu çalışma Parkinson hastalığı olan hastaların yaşam kalitesini de- ğerlendirmek için geliştirilen "Parkinson Hastalığı Yaşam Kalitesi Sorgulama Formu'nun (PDQL-TR)" Türkçe kültürel adaptasyonunu, geçerlilik ve gü- venilirliğini araştırmayı amaçlamıştır. Yöntem: İstanbul Üniversitesi İstanbul Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı'nın polikliniğine Haziran 2005-Nisan 2008 tarihleri arasında başvuran, Parkinson hastalığı tanısı almış 89 hasta çalışmaya dahil edilmiştir. PDQL'in Türkçe versiyonu (PDQL-TR), "Birleştirilmiş Parkinson Hastalığı Derecelendirme Ölçeği" (UPDRS), "Hoehn & Yahr (H & Y) skalası" temel sonuç ölçüm yöntemleri olarak kullanıdı. Bulgular: PDQL-TR, H&Y ve UPDRS skalaları için hesaplanmış Pearson korelasyon katsayısı -0,36 ve-0,80 arasında değişmekteydi. PDQL-TR sorgulama formunun total ve alt grup skorlarının Cronbach alpha katsayısı 0,80'den yüksekti. Madde toplam puan değeri Pearson korelasyon kat sayı- sı 0,40 (4.soru-toplam skor) ve 0,88 (26. soru-toplam skor) arasında değiş- mekteydi, alt-grup toplam skorlarının korelasyon katsayıları ise 0,81 ile 0,96 arasındaydı. PDQL-TR'nin sınıf içi korelasyon sonuçları 0,75 (emosyonel fonksiyon) ve 0,88 (Parkinson semptomları) aralığında yer alarak, yüksek stabilite göstermiştir. Sonuç: PDQL-TR'nin psikometrik özellikleri memnuniyet vericidir ve sonuçlarımız önceki literatür bulgularıyla uyum göstermektedir. PDQL-TR Parkinson hastalığı olan hastaların sağlıkla ilişkili yaşam kalitelerini ölçmede geçerli ve güvenilir bir sorgulama formudur.
Anahtar Kelime: Konular:
Parkinson Hastalığı Yaşam Kalitesi Sorgulama Formu (PDQL-TR)"nun Türkçe Versiyon Çalışması
Öz: Introduction: This study aimed to evaluate Turkish transcultural adaptation, reliability, and validity of "Parkinson's Disease Quality of Life Questionnaire" (PDQL), which has been developed to assess the quality of life of patients with Parkinson's disease. Methods: Eighty-nine patients who were included in the study were diagnosed with Parkinson's disease. They were presented to the outpatient clinic of the Istanbul Faculty of Medicine, Physical Medicine and Rehabilitation department between July 2005 and April 2008. The Turkish translated version of PDQL (PDQL-TR), "Unified Parkinson's Disease Rating Scale" (UPDRS), and Hoehn & Yahr (HY) were used as the main outcome measures. Results: The calculated Pearson correlation coefficient for PDQL, H&Y, and UPDRS ranged between -0.36 and -0.80. Cronbach's alphacoefficients of the PDQL-TR complete questionnaire and subdomains were higher than 0.80. The absolute value of item-total score correlation coefficients by Pearson fluctuated between 0.40 (question 4-total score) and 0.88 (question 26-total score), whereas the subdomain-total score correlation coefficients ranged between 0.81 and 0.96. PDQL-TR showed high stability according to the ICC results, ranging between 0.75 (Emotional Function) and 0.88 (Parkinsonian Symptoms). Conclusion: The psychometric features of PDQL-TR are satisfactory, and our results are consistent with the previous literature findings. PDQLTR is a valid and reliable tool to measure health-related quality of life in patients with Parkinson's disease.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci 2003; 991:1-14. [CrossRef]
- Martinez-Martin P. An introduction to the concept of ''quality of life in Parkin- son's disease''. J Neurol 1998; 245(Suppl 1):S2-6. [CrossRef]
- Schrag A. Quality of life and depression in Parkinson's disease. J Neurol Sci 2006; 248:151-157. [CrossRef]
- Schrag A, Jahanshahi M, Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 2000; 15:1112-1118. [CrossRef]
- Netuveli G, Wiggins RD, Hildon Z, Montgomery SM, Blane D. Functional lim- itation in long standing illness and quality of life: evidence from a national survey. BMJ 2005; 331:1382-1383. [CrossRef]
- Devinsky O. Outcome research in neurology: incorporating health- related quality of life. Ann Neurol 1995; 37:141-142. [CrossRef]
- Marinus J, Ramaker C, van Hilten JJ, Stiggelbout AM. Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments. J Neurol Neurosurg Psychiatry 2002; 72:241-248. [CrossRef]
- Jenkinson C, Fitzpatrick R, Peto V. Health-related quality of life measurement in pa- tients with Parkinson's disease. Pharmacoeconomics 1999; 15:157-165. [CrossRef]
- Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. CMAJ 1986; 134:889-895.
- Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and vali- dation of a short measure of functioning and well-being for individuals with Parkinson's disease. Qual Life Res 1995; 4:241-248. [CrossRef]
- de Boer AG, Wijker W, Speelman JD, de Haes JC. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996; 61:70-74. [CrossRef]
- Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J. Devel- opent and testing of the. Parkinson's disease quality of life scale. Mov Disord 2003; 18:637-645. [CrossRef]
- Yousefi B, Tadibi V, Khoei AF, Montazeri A. Exercise therapy, quality of life, and activities of daily living in patients with Parkinson disease: a small scale quasi-randomised trial. Trials 2009; 10:67. [CrossRef]
- Reuther M, Spottke EA, Klotsche J, Riedel O, Peter H, Berger K, Athen O, Köhne-Volland R, Dodel RC. Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study. Parkinsonism and Relat Disord 2007; 13:108-114. [CrossRef]
- MAPI Institute Web Page. Linguistic Validation; Methodology. Available from URL: http://www.mapi-institute.com/linguistic-validation/methodology.
- Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State". A practical method for grading the state of patients for the clinician. J Psychiatr Res 1975; 12:189- 198. [CrossRef]
- Fahn S, Elton RL, UPDRS program members. Unified Parkinsons Disease Rat- ing Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent developments in Parkinsons disease, Florham Park, NJ: Macmillan Healthcare Information; 1987; p. 153-163.
- Movement Disorder Society Task Force on Rating Scales for Parkinson's Dis- ease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and rec- ommendations. Mov Disord 2003; 18:738-750. [CrossRef]
- Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Mov Disord 2002; 17:867-876. [CrossRef]
- Akbostancı MC, Balaban H, Atbaşoğlu C. Birleşik Parkinson Hastalığı Değer- leme Ölçeği Motor Muayene Bölümü ve Anormal İstemsiz Hareketler Ölçeği'nin değerlendiriciler arası güvenilirlik çalışması. Parkinson Hastalığı ve Hareket Bozuklukları Dergisi 2000; 3:7-13.
- Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neu- rology 1967; 17:427-442. [CrossRef]
- Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG,Wenning GK, Yahr MD, Seidl L; Movement Dis- order Society Task Force on Rating Scales for Parkinson's Disease. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations. Mov Disord 2004; 19:1020-1028. [CrossRef]
- Bland JM, Altman DG. Cronbach's alpha. BMJ 1997; 314:572. [CrossRef]
- Aaronson N, Alonso J, Burnam A, Lohr KN, Patrick DL, Perrin E, Stein RE. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002; 11:193-205. [CrossRef]
- Reiman MP, Manske RC. Essential Concepts and Terms, in Functional Testing in Human Performance. Human Kinetics 2009; p.3-9.
- Nunnally JC. Psychometric Theory, 2nd ed. New York: McGraw-Hill; 1978; p. 245-246.
- Hobson P, Holden A, Meara J. Measuring the impact of Parkinson's disease with the Parkinson's Disease Quality of Life questionnaire. Age Ageing 1999; 28:341-346. [CrossRef]
- Serrano-Duenas M, Serrano S. Psychometric characteristics of PIMS--com- pared to PDQ-39 and PDQL--to evaluate quality of life in Parkinson's disease patients: validation in Spanish (Ecuadorian style). Parkinsonism Relat Disord 2008; 14:126-132. [CrossRef]
- Campos M, de Rezende CH, Farnese VC, da Silva CH, Morales NM, Pinto RM. Translation, Cross-Cultural Adaptation, and Validation of the Parkinson's Disease Quality of Life Questionnaire (PDQL), the "PDQL-BR", into Brazilian Portuguese. ISRN Neurology 2011:1-5. [CrossRef]
- Martinez-Martin P, Serrano-Duenas M, Forjaz MJ, Serrano MS. Two question- naires for Parkinson's disease: are the PDQ-39 and PDQL equivalent? Qual Life Res 2007; 16:1221-1230. [CrossRef]
| APA | DERELİ E, YALIMAN A, KURU ÇOLAKA T, ÇAKMAK REYHAN A, RAZAK ÖZDİNÇLER A, BADILLI DEMİRBAŞ F (2015). Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL). , 128 - 132. |
| Chicago | DERELİ ELİF ELÇİN,YALIMAN AYSE,KURU ÇOLAKA Tuğba,ÇAKMAK REYHAN AYCAN,RAZAK ÖZDİNÇLER Arzu,BADILLI DEMİRBAŞ FEYZA ŞULE Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL). (2015): 128 - 132. |
| MLA | DERELİ ELİF ELÇİN,YALIMAN AYSE,KURU ÇOLAKA Tuğba,ÇAKMAK REYHAN AYCAN,RAZAK ÖZDİNÇLER Arzu,BADILLI DEMİRBAŞ FEYZA ŞULE Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL). , 2015, ss.128 - 132. |
| AMA | DERELİ E,YALIMAN A,KURU ÇOLAKA T,ÇAKMAK REYHAN A,RAZAK ÖZDİNÇLER A,BADILLI DEMİRBAŞ F Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL). . 2015; 128 - 132. |
| Vancouver | DERELİ E,YALIMAN A,KURU ÇOLAKA T,ÇAKMAK REYHAN A,RAZAK ÖZDİNÇLER A,BADILLI DEMİRBAŞ F Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL). . 2015; 128 - 132. |
| IEEE | DERELİ E,YALIMAN A,KURU ÇOLAKA T,ÇAKMAK REYHAN A,RAZAK ÖZDİNÇLER A,BADILLI DEMİRBAŞ F "Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL)." , ss.128 - 132, 2015. |
| ISNAD | DERELİ, ELİF ELÇİN vd. "Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL)". (2015), 128-132. |
| APA | DERELİ E, YALIMAN A, KURU ÇOLAKA T, ÇAKMAK REYHAN A, RAZAK ÖZDİNÇLER A, BADILLI DEMİRBAŞ F (2015). Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL). Nöropsikiyatri Arşivi, 52(2), 128 - 132. |
| Chicago | DERELİ ELİF ELÇİN,YALIMAN AYSE,KURU ÇOLAKA Tuğba,ÇAKMAK REYHAN AYCAN,RAZAK ÖZDİNÇLER Arzu,BADILLI DEMİRBAŞ FEYZA ŞULE Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL). Nöropsikiyatri Arşivi 52, no.2 (2015): 128 - 132. |
| MLA | DERELİ ELİF ELÇİN,YALIMAN AYSE,KURU ÇOLAKA Tuğba,ÇAKMAK REYHAN AYCAN,RAZAK ÖZDİNÇLER Arzu,BADILLI DEMİRBAŞ FEYZA ŞULE Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL). Nöropsikiyatri Arşivi, vol.52, no.2, 2015, ss.128 - 132. |
| AMA | DERELİ E,YALIMAN A,KURU ÇOLAKA T,ÇAKMAK REYHAN A,RAZAK ÖZDİNÇLER A,BADILLI DEMİRBAŞ F Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL). Nöropsikiyatri Arşivi. 2015; 52(2): 128 - 132. |
| Vancouver | DERELİ E,YALIMAN A,KURU ÇOLAKA T,ÇAKMAK REYHAN A,RAZAK ÖZDİNÇLER A,BADILLI DEMİRBAŞ F Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL). Nöropsikiyatri Arşivi. 2015; 52(2): 128 - 132. |
| IEEE | DERELİ E,YALIMAN A,KURU ÇOLAKA T,ÇAKMAK REYHAN A,RAZAK ÖZDİNÇLER A,BADILLI DEMİRBAŞ F "Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL)." Nöropsikiyatri Arşivi, 52, ss.128 - 132, 2015. |
| ISNAD | DERELİ, ELİF ELÇİN vd. "Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL)". Nöropsikiyatri Arşivi 52/2 (2015), 128-132. |
